SHARE - Symbicort and Health Economics in a Real Life Evaluation

Summary

The purpose of this study is to compare health-related costs and asthma control in ordinary clinical practice during 12 months for Symbicort® given as a low maintenance dose plus as needed compared to a free combination of Pulmicortâ and Oxis® plus Bricanyl® as needed, and Symbicort fixed dosing plus Bricanyl as needed in asthmatic patients not adequately controlled on inhaled glucocorticosteroids alone.

Timeline

Start

2004-04

Primary completion

—

Completion

2007-05

Drugs

Indications